* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : pulmonology;
True Meta (CISMeF) : O;
Origin ID : MT34;
ATC codes
CISMeF Querying Strategi(ies)
CISMeF Resource Types
False automatic mappings
ICD-10 codes
- Asthma [ICD-10 category (who)]
- Cough [ICD-10 category (who)]
- Pleura [ICD-10 Sub-category (who)]
- Thorax [ICD-10 Sub-category (who)]
- Trachea [ICD-10 Sub-category (who)]
- Trachea [ICD-10 Sub-category (who)]
ICD-11 codes
MeSH
SNOMED CT concepts
SNOMED int. notions
See also
See also (suggested by CISMeF)
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording
---
https://ansm.sante.fr/tableau-marr/apixaban
2025
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout
---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2025
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rybrevant
2025
false
false
false
Netherlands
French
English
amivantamab
amivantamab
amivantamab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
rybrevant
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
adult
aged
carcinoma, non-small-cell lung
bronchial neoplasms
Activating EGFR Exon 20 Mutation
carcinoma, non-small-cell lung
bronchial neoplasms
Gain of Function Mutation
genes, erbb-1
Refractory Lung Non-Small Cell Carcinoma
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
---
https://ansm.sante.fr/tableau-acces-derogatoire/xalkori
2025
false
false
false
France
French
drug information
administration, oral
Crizotinib
antineoplastic agents
protein kinase inhibitors
capsules
pharmaceutical solutions
child
infant
lymphoma, large-cell, anaplastic
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
crizotinib
MET Exon 14 Mutation
Locally Advanced Lung Non-Small Cell Carcinoma
adult
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
continuity of patient care
---
https://ansm.sante.fr/tableau-acces-derogatoire/imfinzi-50-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
durvalumab
guidelines for drug use
Unresectable Biliary Tract Carcinoma
antineoplastic combined chemotherapy protocols
Metastatic Biliary Tract Carcinoma
durvalumab
adult
Cisplatin/Durvalumab/Gemcitabine Regimen
infusions, intravenous
cisplatin
carcinoma, hepatocellular
carcinoma, non-small-cell lung
small cell lung carcinoma
bronchial neoplasms
---
https://ansm.sante.fr/tableau-acces-derogatoire/selpercatinib-20-40-et-80mg-gelule
2025
false
false
false
France
French
selpercatinib
administration, oral
carcinoma, non-small-cell lung
advanced RET fusion-positive non-small cell lung cancer
Product containing only selpercatinib in oral dose form (medicinal product form)
thyroid cancer, medullary
drug information
selpercatinib
pyrazoles
pyridines
---
https://ansm.sante.fr/tableau-acces-derogatoire/opdivo-nivolumab-solution-a-diluer-pour-perfusion-yervoy-ipilimumab-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
guidelines for drug use
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
Malignant Pleural Mesothelioma
disease progression
Progressive Neoplastic Disease
infusions, intravenous
continuity of patient care
drug monitoring
carcinoma, non-small-cell lung
melanoma
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIIB Cutaneous Melanoma AJCC v7
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/arikayce-liposomal
2025
false
false
false
France
French
guidelines for drug use
mycobacterium infections, nontuberculous
amikacin
liposomes
administration, inhalation
pneumonia, bacterial
anti-bacterial agents
Mycobacterium abscessus
amikacin
Infection caused by Mycobacteroides abscessus (disorder)
---
https://www.palliaguide.be/toux-soins-palliatifs/
2025
false
false
false
Belgium
French
practice guideline
palliative care
cough
cough
cough
antitussive agents
---
https://drees.solidarites-sante.gouv.fr/publications-communique-de-presse/etudes-et-resultats/250403_ER_patients-soins-critiques-covid-19-risques
2025
France
journal article
patient care
risk
mechanical ventilation, nos
has patient
COVID-19
death
critical care
respiration, artificial
ventilation, mechanical
vulnerable populations
Disadvantaged Populations
---
https://www.has-sante.fr/jcms/p_3599701/fr/beclometasone-formoterol-biogaran-beclometasone-/-formoterol-asthme-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, inhalation
formoterol and beclometasone
evaluation of the transparency committee
asthma
beclomethasone
pulmonary disease, chronic obstructive
Formoterol Fumarate
---
https://www.chu-lyon.fr/syndrome-apnees-sommeil
2025
France
popular works
obstructive sleep apnea syndrome
sleep apnea, obstructive
---
https://www.has-sante.fr/jcms/p_3600306/fr/fluenz-vaccin-grippal-trivalent-vivant-attenue-nasal-vaccin-antigrippal
2025
France
evaluation of the transparency committee
influenza vaccines
vaccination
vaccines, attenuated
preventive immunization/medication
attenuated by
nose, nos
influenza virus vaccine
---
https://www.cochrane.org/fr/CD013835/CENTRALED_le-risque-de-deces-differe-t-il-entre-adultes-de-sexe-feminin-et-masculin-atteints-dembolie
2025
United Kingdom
review of literature
french abstract
pulmonary embolism
adulthood
safe sex
pulmonary embolism
female, nos
Male
risk
disease
sex
death
pulmonary embolism
unsafe sex
blood
female
lung
male, nos
adult
---
https://www.cochrane.org/fr/CD016039/CENTRALED_les-antibiotiques-peuvent-ils-controler-ou-eradiquer-linfection-par-des-mycobacteries-non
2025
United Kingdom
review of literature
french abstract
uncontrolled
cystic fibrosis
antibiotic, nos
tuber, nos
persons
mycobacterium, nos
disease
antibiotics
mycobacterium infections, nontuberculous
lung
infection control
anti-bacterial agents
infectious disease, nos
cystic fibrosis
---
https://www.irdes.fr/recherche/2025/qes-297-consequences-de-la-pandemie-de-covid-19-sur-la-mortalite-de-patients-atteints-de-maladies-respiratoires.html
2025
France
journal article
chronic obstructive lung disease, nos
chronic disease
patients
COVID-19
snacks
neoplasm, malignant
disease
chronic respiratory disease, nos
lung cancer
chronically ill
airway obstruction
pulmonary disease, chronic obstructive
pandemics
has patient
lung neoplasms
mortality
---
https://publications.msss.gouv.qc.ca/msss/document-002135/
2025
Canada
algorithms
guideline
neonatal screening, nos
patient care management
cystic fibrosis
cystic fibrosis
fibrosis
neonatal screening
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/detection-de-lenterocoque-resistant-a-la-vancomycine-erv.html
2025
Canada
technical report
vancomycin
diffuse rigidity
detective
Vancomycin-Resistant Enterococci
---
https://antibioresistance.fr/ressources/prevention_IAS/PRIMO_Recommandations_EPI_gestion_IRA_ESMS.pdf
2025
France
scientific and technical information
Personal Protective Equipment
acute infectious disease
respiratory tract infections
patient care management
health planning guidelines
---
https://www.chu-lyon.fr/cancer-mesotheliome
2025
France
popular works
pleural neoplasms
neoplasm, malignant
cancer
pleura
mesothelioma
---
https://www.has-sante.fr/jcms/p_3605182/fr/prevenar-20-vaccin-pneumococcique-polyosidique-conjugue-20-valent-adsorbe-ou-vpc20-infections-a-pneumocoques
2025
false
false
false
France
evaluation of the transparency committee
preventive immunization/medication
vaccination
pneumococcal infections
prevenar
pneumococcal infectious disease, nos
polysaccharides
pneumococcal polysaccharide vaccine
pneumococcal vaccination
pneumococcal vaccines
vaccines, conjugate
---
https://www.has-sante.fr/jcms/p_3604202/fr/rybrevant-amivantamab-cancer-bronchique-non-a-petites-cellules-exon-19-exon-21
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
amivantamab
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
bronchial neoplasms
infusions, intravenous
Antineoplastic Agents, Immunological
antibodies, bispecific
Amivantamab/Carboplatin/Pemetrexed Regimen
antineoplastic combined chemotherapy protocols
carboplatin
Pemetrexed
adult
EGFR NP_005219.2:p.L858R
EGFR Exon 19 Deletion Mutation
evaluation of the transparency committee
amivantamab
bronchial neoplasms
---
https://www.has-sante.fr/jcms/p_3605179/fr/tagrisso-osimertinib-cancer-du-poumon
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
osimertinib
antineoplastic agents
Tyrosine Kinase Inhibitors
adult
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
Locally Advanced Unresectable Lung Non-Small Cell Carcinoma
lung neoplasms
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
evaluation of the transparency committee
lung neoplasms
osimertinib
---
https://www.academie-medecine.fr/vaccination-des-femmes-enceintes-contre-les-maladies-respiratoires-ne-plus-hesiter/
2025
France
scientific and technical information
respiratory tract diseases
vaccination
vaccination, nos
preventive immunization/medication
disease of respiratory system, nos
disease
vaccination
Pregnant People
pregnancy, nos
---
https://www.has-sante.fr/jcms/p_3606289/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire-htap
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
drug therapy, combination
respiratory system agents
sotatercept
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
injections, subcutaneous
evaluation of the transparency committee
sotatercept
Pulmonary Arterial Hypertension
---
https://www.has-sante.fr/jcms/p_3604199/fr/rybrevant-amivantamab-cancer-bronchique-non-a-petites-cellules-exon-20
2025
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
antibodies, bispecific
amivantamab
amivantamab
infusions, intravenous
Antineoplastic Agents, Immunological
bronchial neoplasms
carcinoma, non-small-cell lung
antineoplastic combined chemotherapy protocols
Amivantamab/Carboplatin/Pemetrexed Regimen
carboplatin
Pemetrexed
adult
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
---
https://www.has-sante.fr/jcms/p_3609085/fr/imfinzi-durvalumab-cancer-de-la-vessie
2025
false
false
false
France
evaluation of the transparency committee
durvalumab
malignant neoplasm of bladder
Imfinzi
neoplasm, malignant
urinary bladder cancer
urinary bladder neoplasms
durvalumab
---
https://www.chu-lyon.fr/education-therapeutique-et-mucoviscidose-age-adulte
2025
France
popular works
age, nos
education
patient education as topic
therapeutics
cystic fibrosis
adulthood
adult
aged
cystic fibrosis
---
https://www.has-sante.fr/jcms/p_3508311/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept
---
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet
---
https://www.has-sante.fr/jcms/p_3573729/fr/interet-des-techniques-d-amplification-des-acides-nucleiques-taan-multiplex-dans-la-prise-en-charge-medicale-des-infections-respiratoires-basses
2025
false
false
false
France
Lower respiratory tract infection (disorder)
health technology assessment
respiratory tract infections
nucleic acid amplification techniques
---
https://www.has-sante.fr/jcms/p_3574058/fr/transition-du-vaccin-antigrippal-influvac-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
influenza virus vaccine
influenza
influvac
preventive immunization/medication
vaccination
influenza vaccination
influenza, human
health planning guidelines
vaccination
influenza vaccines
influvac
due to
---
https://www.has-sante.fr/jcms/p_3575597/fr/choix-et-durees-d-antibiotherapies-pneumonie-aigue-communautaire-de-l-adulte-en-ambulatoire
2025
France
practice guideline
pneumonia, nos
pneumonia
choice behavior
adulthood
pneumonia
adult
community-acquired pneumonia
antibiotic therapy
---
https://www.has-sante.fr/jcms/p_3575612/fr/choix-et-durees-d-antibiotherapie-pneumonie-aigue-communautaire-chez-l-enfant
2025
France
practice guideline
pneumonia
antibiotic therapy
choice behavior
child, nos
community-acquired pneumonia
pneumonia
pneumonia, nos
child
---
https://www.has-sante.fr/jcms/p_3574253/fr/ventoline-salbutamol-asthme
2025
false
false
false
France
injections, subcutaneous
acute disease
evaluation of the transparency committee
albuterol
asthma
---
https://www.has-sante.fr/jcms/p_3577036/fr/kalydeco-ivacaftor-mucoviscidose
2025
false
false
false
France
infant
treatment outcome
insurance, health, reimbursement
administration, oral
ivacaftor
evaluation of the transparency committee
cystic fibrosis
ivacaftor
---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/grippe/documents/bulletin-national/infections-respiratoires-aigues-grippe-bronchiolite-covid-19-.-bulletin-du-8-janvier-2025
2025
France
journal article
acute bronchiolitis, nos
acute infectious disease
bronchiolitis
Infections
COVID-19
newsletters
influenza, nos
periodicals as topic
influenza, human
influenza
---
https://www.chu-lyon.fr/etp-patients-hypertension-arterielle-pulmonaire
2025
France
popular works
patient education as topic
hypertensive disease, nos
schedules, patient
appointments and schedules
pulmonary hypertension, nos
has patient
disease
Pulmonary Arterial Hypertension
---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digital-joe
2025
France
health technology assessment
asthma
Pediatricians
pediatrics
pediatrician
asthma
asthma, nos
therapy, nos
digitalis, nos
digitalis
digitalis glycosides
---
https://www.chu-lyon.fr/deficit-en-alpha-1-antitrypsine-aat
2025
France
popular works
alpha 1-Antitrypsin
aortic aneurysm, thoracic
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency
---
https://www.has-sante.fr/jcms/p_3578223/fr/therapie-digitale-joe
2025
France
health technology assessment
asthma, nos
digitalis, nos
asthma
therapy, nos
Pediatricians
asthma
digitalis
pediatrician
pediatrics
---
https://www.has-sante.fr/jcms/p_3587072/fr/krazati-adagrasib-cancer-bronchique-non-a-petites-cellules
2025
false
false
false
France
adagrasib
KRAS NP_004976.2:p.G12C
KRAS Gene Mutation
evaluation of the transparency committee
adagrasib
carcinoma, non-small-cell lung
---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/bpco-et-insuffisance-respiratoire-chronique/documents/rapport-synthese/surveillance-des-maladies-respiratoires-chroniques-chez-les-travailleurs-affilies-au-regime-general.-prevalences-et-secteurs-d-activite-et-professi
2025
France
technical report
dataset
chronic disease
chronic respiratory disease, nos
Chronic Disease Indicators
chronically ill
occupation, nos
risk
diet, nos
respiratory tract diseases
occupations
general practitioners
prevalence
including
---
https://www.santepubliquefrance.fr/presse/2025/asthme-accident-vasculaire-cerebral-diabete-quels-impacts-de-la-pollution-de-l-air-ambiant-sur-la-sante-et-quel-impact-economique
2025
France
popular works
cost savings
air pollution, indoor
cerebrovascular accident, nos
economics
health
asthma
air pollution
asthma
air pollution
diabetes mellitus
stroke
Embolic Stroke
stroke/cerebrovascular accident
asthma, nos
---
https://www.santepubliquefrance.fr/content/download/694367/4560433?version=1
2025
France
scientific and technical information
cerebrovascular accident, nos
asthma
stroke
air pollution, indoor
asthma
stroke/cerebrovascular accident
health
air pollution
air pollution
diabetes mellitus
asthma, nos
economics
cost savings
Embolic Stroke
---
https://ansm.sante.fr/actualites/benfluorex-conclusions-du-rapport-2020-2023-de-surveillance-des-cas-dhypertension-arterielle-pulmonaire
2025
false
false
false
France
French
technical report
health surveys
hypertension, pulmonary
benfluorex
pharmacovigilance
benfluorex
---
https://ansm.sante.fr/tableau-marr/pseudoephedrine
2025
false
false
false
France
French
pseudoephedrine
risk management
drug information
patients guideline
nasal decongestants
drug combinations
administration, oral
pseudoephedrine, combinations
common cold
---
https://www.has-sante.fr/jcms/p_3527462/fr/retsevmo-selpercatinib-cancer-de-la-thyroide
2025
false
false
false
France
adult
adolescent
treatment outcome
insurance, health, reimbursement
administration, oral
selpercatinib
advanced RET fusion-positive thyroid cancer
RET Fusion Positive
thyroid cancer, medullary
carcinoma, neuroendocrine
Advanced Thyroid Gland Medullary Carcinoma
RET Inhibitor
antineoplastic agents
evaluation of the transparency committee
selpercatinib
thyroid neoplasms
---
https://ansm.sante.fr/actualites/heparine-calcique-en-seringue-preremplie-tensions-dapprovisionnement-et-arret-de-commercialisation
2025
false
false
false
France
French
drug information
guideline
calcium heparin
injections, subcutaneous
Pre-filled Syringe
heparin
patients guideline
anticoagulants
---
https://ansm.sante.fr/actualites/point-de-situation-sur-les-appareils-de-ventilation-philips
2025
false
false
false
France
French
ventilators, mechanical
Defective Device
scientific and technical information
home nursing
respiration, artificial
---
https://ansm.sante.fr/dossiers-thematiques/le-remplacement-des-machines-presentant-un-defaut-qualite
2025
false
false
false
France
French
ventilators, mechanical
Defective Device
equipment and supplies note
product surveillance, postmarketing
home nursing
respiration, artificial
continuous positive airway pressure
---
https://www.has-sante.fr/jcms/p_3589935/fr/kinox-monoxyde-d-azote-vasodilatateur-inhale
2025
false
false
false
France
adult
infant, newborn
adolescent
child
infant
nitric oxide
perioperative pulmonary hypertension
postoperative pulmonary hypertension
cardiac surgical procedures
evaluation of the transparency committee
nitric oxide
administration, inhalation
hypertension, pulmonary
respiratory distress syndrome, newborn
---
https://www.has-sante.fr/jcms/p_3590117/fr/vaccin-antigrippal-vaxigrip-transition-du-vaccin-antigrippal-vaxigrip-de-sa-forme-quadrivalente-a-une-forme-trivalente-dans-la-strategie-de-vaccination-contre-la-grippe-saisonniere
2025
France
public health guidelines
influenza vaccination
health planning guidelines
vaxigrip
vaccinia virus vaccine
influenza
influenza, human
influenza virus vaccine
influenza vaccines
vaccination
vaccination
preventive immunization/medication
due to
vaxigrip
influenza A virus
---
https://www.has-sante.fr/jcms/p_3590636/fr/imfinzi-durvalumab-cancer-de-l-endometre
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
Antineoplastic Agents, Immunological
durvalumab
antineoplastic combined chemotherapy protocols
Mismatch Repair Deficiency
adult
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
neoplasm recurrence, local
infusions, intravenous
evaluation of the transparency committee
durvalumab
endometrial neoplasms
---
https://www.has-sante.fr/jcms/p_3590639/fr/imfinzi-lynparza-durvalumab/olaparib-cancer-de-l-endometre
2025
false
false
false
France
antineoplastic combined chemotherapy protocols
insurance, health, reimbursement
treatment outcome
Antineoplastic Agents, Immunological
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
Mismatch Repair Proficient
Mismatch Repair Deficiency
durvalumab
durvalumab
olaparib
olaparib
evaluation of the transparency committee
endometrial neoplasms
---
https://www.has-sante.fr/jcms/p_3594723/fr/influvac-vaccin-grippal-inactive-a-antigenes-de-surface-vaccin-antigrippal
2025
false
false
false
France
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN B
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H3N2)
INFLUENZA VIRUS INACTIVATED SURFACE ANTIGEN STRAIN A (H1N1)
Trivalent Influenza Vaccine
evaluation of the transparency committee
influenza vaccines
preventive immunization/medication
hepatitis surface antigen
influenza virus vaccine
vaccines, inactivated
antigens, surface
vaccination
---
https://www.srlf.org/media/podcast-larret-cardio-respiratoire-acr-lenfant-interview-du-dr-david-brossier
2025
France
sound
respiratory arrest
child
child, nos
---
https://ansm.sante.fr/informations-de-securite/emblaveo-aztreonam-avibactam-1-5-g-0-5-g-poudre-pour-solution-a-diluer-pour-perfusion-risque-potentiel-de-flacons-fissures-ou-casses
2025
false
false
false
France
French
pharmacovigilance note
---
https://www.has-sante.fr/jcms/p_3594958/fr/vaxigrip-vaccin-grippal-trivalent-inactive-a-virion-fragmente-vaccin-antigrippal
2025
France
evaluation of the transparency committee
vaccination
vaxigrip
preventive immunization/medication
fragmentation, nos
influenza virus vaccine
virion
influenza vaccines
vaccines, inactivated
vaxigrip
---
https://www.cochrane.org/fr/CD011196/CENTRALED_quelle-est-la-precision-de-la-detection-du-dioxyde-de-carbone-pour-determiner-si-une-sonde-inseree
2025
United Kingdom
review of literature
french abstract
mouth
carbon dioxide
blocked nose
carbon, nos
child
stomach
sound, nos
nose
catheterization
detective
airway, nos
child, nos
---
https://www.has-sante.fr/jcms/p_3597606/fr/krazati-adagrasib-cancer-bronchique-non-a-petites-cellules-avance-cbnpc
2025
false
false
false
France
bronchial neoplasms
treatment outcome
insurance, health, reimbursement
administration, oral
antineoplastic agents
adagrasib
adult
KRAS G12C Inhibitor
KRAS NP_004976.2:p.G12C
evaluation of the transparency committee
carcinoma, non-small-cell lung
adagrasib
---
https://www.has-sante.fr/jcms/p_3459735/fr/evaluation-des-strategies-de-depistage-et-de-reperage-precoce-de-la-tuberculose-pulmonaire
2025
France
public health guidelines
mass screening
respiratory tuberculosis
tuberculosis
tuberculosis, pulmonary
evaluation studies as topic
early medical intervention
screening
early diagnosis
---
https://www.has-sante.fr/jcms/p_3598771/fr/tuberculose-pulmonaire-structurer-le-depistage-et-le-reperage-precoce-dans-les-populations-a-risque
2025
France
scientific and technical information
early medical intervention
tuberculosis, pulmonary
risk assessment
tuberculosis
communication
population at risk
mass media
press releases
communism
respiratory tuberculosis
risk factors
screening
early diagnosis
---
https://www.inspq.qc.ca/publications/3633
2025
Canada
technical report
quebec
organization and administration
Infections
Vancomycin-Resistant Enterococci
resistance to infection, nos
vancomycin
---
https://www.cancer.fr/presse/depistage-des-cancers-du-poumon-et-vaccination-contre-les-cancers-hpv-l-institut-national-du-cancer-s-adresse-aux-medecins-generalistes-a-l-occas
2025
France
scientific and technical information
general practitioners
screening
papillomavirus vaccines
general practice
general physician, nos
lung
vaccination, nos
congresses as topic
vaccination
national cancer institute (U.S.)
institutes
mass screening
viral disease other/nos
preventive immunization/medication
cancer
vaccination
neoplasm, malignant
---
https://www.ema.europa.eu/en/medicines/human/EPAR/apexelsin
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
paclitaxel
paclitaxel
---
https://www.ema.europa.eu/en/medicines/human/EPAR/winrevair
2025
false
false
false
Netherlands
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
treatment outcome
sotatercept
sotatercept
orphan drug production
sotatercept
hypertension, pulmonary
injections, subcutaneous
drug approval
europe
adult
drug therapy, combination
activins
risk management
pregnancy
breast feeding
aged
drug evaluation, preclinical
---
Fluenz - influenza vaccine (live attenuated, nasal)
https://www.ema.europa.eu/en/medicines/human/EPAR/fluenz
2025
false
false
false
France
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
influenza, human
influenza vaccines
vaccination
Trivalent Live-Attenuated Influenza Vaccine
---
https://ansm.sante.fr/tableau-acces-derogatoire/avastin-r-25-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
Bevacizumab
drug information
guidelines for drug use
intravitreal injections
macular degeneration
Neovascular age-related macular degeneration
---
https://ansm.sante.fr/actualites/rifampicine-conduites-a-tenir-dans-un-contexte-de-fortes-tensions-dapprovisionnement
2025
false
false
false
France
French
rifampin
france
administration, oral
infusions, intravenous
guidelines for drug use
antibiotics, antitubercular
-
-
-
osteoarticular infections
tuberculosis
Infection associated with device (disorder)
Infection associated with vascular device (disorder)
Staphylococcal endocarditis (disorder)
---
https://ansm.sante.fr/dossiers-thematiques/plan-hivernal
2025
false
false
false
France
French
guideline
anti-bacterial agents
glucocorticoids
anti-asthmatic agents
continuity of patient care
break in supply
Drug Shortage
antipyretics
Product supply issue
drug information
---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2025
false
false
false
France
French
summary of product characteristics
amivantamab
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
carcinoma, non-small-cell lung
guidelines for drug use
package leaflet
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
EGFR Exon 20 Insertion Mutation
---
https://ansm.sante.fr/actualites/amoxicilline-des-recommandations-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2025
false
false
false
France
French
amoxicillin
guidelines for drug use
amoxicillin
administration, oral
infant
child
amoxicillin
amoxicillin-potassium clavulanate combination
amoxicillin-potassium clavulanate combination
amoxicillin and beta-lactamase inhibitor
---
https://www.has-sante.fr/jcms/p_3526093/fr/adempas-riociguat-hypertension-arterielle-pulmonaire-htap-et-hypertension-pulmonaire-thromboembolique-chronique-htp-tec
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
Chronic thromboembolic pulmonary hypertension
riociguat
administration, oral
evaluation of the transparency committee
riociguat
Pulmonary Arterial Hypertension
---
https://www.has-sante.fr/jcms/p_3526078/fr/seebri-breezhaler-bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
glycopyrronium bromide
treatment outcome
insurance, health, reimbursement
administration, inhalation
bronchodilator agents
hospitals
evaluation of the transparency committee
pulmonary disease, chronic obstructive
glycopyrrolate
---
https://ansm.sante.fr/actualites/les-ventilateurs-puritan-bennett-500-doivent-etre-remplaces-par-une-alternative
https://ansm.sante.fr/informations-de-securite/ventilateur-puritan-bennet-serie-500-medtronic
2024
false
false
false
France
French
equipment and supplies note
Safety-Based medical device withdrawals
ventilators, mechanical
neoplasms
---
https://www.arcagy.org/infocancer/localisations/appareil-respiratoire-orl/mesotheliome-pleural.html/
2024
France
popular works
Pleural Mesothelial Neoplasm
cancer
pleural neoplasms
Asbestos-Related Malignant Neoplasm
asbestos
asbestos, nos
neoplasm, malignant
mesothelioma
Malignant Pleural Neoplasm
---
https://ansm.sante.fr/actualites/en-cas-de-rhume-evitez-les-medicaments-vasoconstricteurs-par-voie-orale
2024
false
false
false
France
French
common cold
administration, oral
nasal decongestants
pseudoephedrine
pharmacovigilance note
patients guideline
nasopharyngitis
pseudoephedrine, combinations
myocardial infarction
stroke
Posterior reversible encephalopathy syndrome (disorder)
Reversible cerebral vasoconstriction syndrome (disorder)
---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-corgard-80-mg-nadolol-ce-medicament-doit-etre-reserve-a-certains-patients-atteints-de-troubles-du-rythme-dorigine-genetique
2024
false
false
false
France
French
nadolol
drug information
guideline
patient education handout
Genetic cardiac rhythm disease
arrhythmias, cardiac
nadolol
arrhythmias, cardiac
---
https://publications.msss.gouv.qc.ca/msss/document-003669/
2024
false
false
false
Canada
patient education handout
respiratory tract diseases
Disease or Disorder
Respiratory System
health
disease
Respiratory System Finding
disease of respiratory system, nos
---
https://ansm.sante.fr/tableau-marr/epoprostenol
2024
false
false
false
France
French
patients guideline
risk management
Infection of intravenous catheter (disorder)
Infection of intravenous catheter (disorder)
central venous catheters
epoprostenol
drug information
---
https://ansm.sante.fr/tableau-acces-derogatoire/mabthera-100-mg-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
infusions, intravenous
Product containing precisely rituximab 10 milligram/1 milliliter conventional release
solution for infusion (clinical drug)
Rituximab
drug information
guidelines for drug use
Refractory immune thrombocytopenic purpura
purpura, thrombocytopenic, idiopathic
immunologic factors
technical report
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/maladie-pulmonaire-obstructive-chronique.html
2024
false
false
false
Canada
practice guideline
lung diseases
pulmonary disease, chronic obstructive
Diseases
chronic obstructive lung disease, nos
chronic disease
Chronic disease
---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag
---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child
---
https://ansm.sante.fr/tableau-acces-derogatoire/keytruda-25-mg-ml-solution-a-diluer-pour-perfusion#
2024
false
false
false
France
French
drug information
triple negative breast neoplasms
pembrolizumab
pembrolizumab
guidelines for drug use
adult
Early Stage Triple-Negative Breast Carcinoma
Locally Advanced Triple-Negative Breast Carcinoma
inflammatory breast neoplasms
Antineoplastic Agents, Immunological
endometrial neoplasms
clear cell renal cell carcinoma
renal cell carcinoma at increased risk of recurrence following nephrectomy, or following
nephrectomy and resection of metastatic lesions
antineoplastic combined chemotherapy protocols
Enfortumab Vedotin/Pembrolizumab Regimen
Unresectable Urothelial Carcinoma
Metastatic Urothelial Carcinoma
urologic neoplasms
carcinoma
---
2024
false
false
false
France
French
osimertinib
summary of product characteristics
package leaflet
guidelines for drug use
administration, oral
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
mutation
bronchial neoplasms
bronchial neoplasms
EGF Receptors
antineoplastic agents
antineoplastic agents
protein kinase inhibitors
protein kinase inhibitors
osimertinib
EGFR NP_005219.2:p.L858R
EGFR Exon 19 Deletion Mutation
ErbB Receptors
acrylamides
aniline compounds
---
https://ansm.sante.fr/tableau-atu-rtu/gavreto-100-mg-gelule
2024
false
false
false
France
French
pralsetinib
antineoplastic agents
guidelines for drug use
pralsetinib
pyrazoles
pyridines
pyrimidines
---
https://www.cochrane.org/fr/CD003214/NEONATAL_quels-sont-les-benefices-et-les-risques-des-bronchodilatateurs-inhales-chez-les-nouveau-nes
2024
false
true
false
United Kingdom
France
infant, premature
infant, newborn
treatment outcome
bronchodilator agents
lung diseases
meta-analysis
french abstract
lung diseases
bronchodilator agents
chronic disease
---
https://ansm.sante.fr/tableau-marr/atezolizumab
2024
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
drug information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal
---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2024
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized
---
https://ansm.sante.fr/tableau-marr/rituximab
2024
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding
---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101217/n/validation-questionnaire-depistage-asthme-travail-qdart-l-tm-
2024
Canada
technical report
detective
asthma
mass screening
work
asthma, nos
questionnaires
screening
early diagnosis
occupation, nos
asthma
---
https://cps.ca/fr/documents/position/les-strategies-de-prevention-du-virus-respiratoire-syncytial-pour-la-saison-de-maladies-respiratoires-virales-2024-2025
2024
Canada
public health guidelines
virus diseases
disease of respiratory system, nos
viral disease, nos
respiratory tract diseases
seasons
respiratory syncytial viruses
respiratory syncytial virus
---
https://www.has-sante.fr/jcms/p_3555565/fr/imfinzi-durvalumab-carcinome-hepatocellulaire-chc
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
durvalumab
evaluation of the transparency committee
carcinoma, hepatocellular
durvalumab
---
https://www.inspq.qc.ca/publications/3578
2024
Canada
technical report
Vancomycin-Resistant Enterococci
quebec
Infections
vancomycin
resistance to infection, nos
---
https://www.usherbrooke.ca/baladocritique/archives/episode-65-etude-revise
2024
Canada
sound
ventilation, mechanical
episode of
data collection
ulcer
stress ulcer, nos
mechanical ventilation, nos
prophylactic treatment, nos
stress, physiological
respiration, artificial
---
https://dumas.ccsd.cnrs.fr/dumas-04673519
2024
France
dissertations, academic
review literature as topic
Systematic Review
respiratory arrest
classification
patient care management
---
https://dumas.ccsd.cnrs.fr/dumas-04771273
2024
France
dissertations, academic
outpatients
meta-analysis as topic
Meta-Analysis
unknown (origin)
disease
fibrosis of lung, nos
classification
idiopathic pulmonary fibrosis
residence characteristics
domicile
has patient
Systematic Review
---
https://theses.fr/2024TLSES060
2024
France
dissertations, academic
emergency medicine
evaluation studies as topic
dyspnea, nos
adult
dyspnea
adulthood
---
https://www.sfpediatrie.com/sites/www.sfpediatrie.com/files/medias/documents/Communiqu%C3%A9_SFP_20112024_VF.pdf
2024
France
scientific and technical information
bronchiolitis
alarm, nos
nirsevimab
child, nos
respiratory syncytial viruses
bronchiolitis, nos
family
Pediatricians
child
pediatrics
residence characteristics
nirsevimab
pediatrician
family, nos
community
---
https://www.has-sante.fr/jcms/p_3557276/fr/alecensa-alectinib-cancer-bronchique-non-a-petites-cellules-cbnpc
2024
false
false
false
France
bronchial neoplasms
treatment outcome
insurance, health, reimbursement
alectinib
Adjuvant Therapy
ALK Positive
adult
recurrence
administration, oral
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
carcinoma, non-small-cell lung
alectinib
---
https://www.srlf.org/article/dyspnee-severe-si-lintubation-netait-qua-souffle
2024
France
critical appraisal or critical reading
dyspnea
intubation
due to
intubation, nos
dyspnea, nos
blast
severe
---
https://www.has-sante.fr/jcms/p_3483264/fr/fluenz-tetra-vaccin-grippal-quadrivalent-vivant-attenue-nasal-vaccin-antigrippal
2024
false
false
false
France
evaluation of the transparency committee
Trivalent Live-Attenuated Influenza Vaccine
preventive immunization/medication
Nasal Route of Administration
Trial Element Duration
Influenza Vaccine
influenza virus vaccine
vaccines, attenuated
Quadrivalent Influenza Vaccine
Nasal Dosage Form
vaccination
nose, nos
influenza vaccines
Tea Leaf
Ezatiostat Hydrochloride
attenuated by
---
https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive
---
https://www.has-sante.fr/jcms/p_3487169/fr/tagrisso-osimertinib-cancer-bronchique-non-a-petites-cellules-cbnpc
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
bronchial neoplasms
administration, oral
antineoplastic agents
osimertinib
adult
evaluation of the transparency committee
carcinoma, non-small-cell lung
osimertinib
---
https://www.has-sante.fr/jcms/p_3478096/fr/kalydeco-ivacaftor-mucoviscidose
2024
false
false
false
France
infant
child
evaluation of the transparency committee
ivacaftor
cystic fibrosis
ivacaftor
Ivacaftor
Cystic Fibrosis
cystic fibrosis
kalydeco
ivacaftor
---
https://ansm.sante.fr/informations-de-securite/adagrasib-risque-potentiel-deffets-indesirables-cutanes-severes
2024
false
false
false
France
French
pharmacovigilance note
risk
adagrasib
stevens-johnson syndrome
epidermal necrolysis, toxic
adagrasib
antineoplastic agents
Adagrasib Regimen
---
https://www.has-sante.fr/jcms/p_3487904/fr/xolair-omalizumab-polypose-naso-sinusienne
2024
false
false
false
France
nasal polyps
Polyp of nasal cavity and/or nasal sinus (disorder)
evaluation of the transparency committee
xolair
Omalizumab
Polyposis
Omalizumab
---
https://www.has-sante.fr/jcms/p_3490836/fr/enoxaparine-crusia-enoxaparine-sodique-thrombose-veineuse-profonde-tvp-et-embolie-pulmonaire-ep
2024
false
false
false
France
evaluation of the transparency committee
enoxaparin
embolism and thrombosis
pulmonary embolism
Deep Vein Thrombosis
venous thrombosis
pulmonary embolism
Enoxaparin Sodium
Venous Embolism
Pulmonary Embolism
deep vein thrombosis
deep thrombophlebitis, nos
pulmonary embolism
---
https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone
---
https://www.santepubliquefrance.fr/presse/2024/impact-de-la-pollution-de-l-air-dans-les-etablissements-scolaires-sur-l-asthme-des-enfants-de-6-a-11-ans-sante-publique-france-presente-les-premi
2024
France
scientific and technical information
CHFR Gene
Impact
Smoking at Diagnosis
schools
Loss of Chromosome 11
Severity of Symptom Score 6
resulting in
Offspring
french
Six
public health
child, nos
Clinical Status Ordinal Scale Outcome 6
Arginine/Omega-3 Fatty Acids/Nucleotides Oral Supplement
Child
Air
Thought Score 6
asthma
Illness Intrusiveness Rating 6
Child Health
Autonomic Nervous System
Public Health
Fear Score 6
air pollution
Asthma
air pollution
Asthma Pathway
Eleven
asthma
Established
france
asthma, nos
---
https://www.sfmg.org/actualites/communiques/la_prevention_des_infections_a_virus_respiratoire_syncytial_vrs.html
2024
France
scientific and technical information
respiratory syncytial virus infection, nos
Prevention Study
Preventive Intervention
Vienna Rectoscopy Score
Chuvash Language
Respiratory Syncytial Virus Infection
respiratory syncytial virus infections
respiratory syncytial viruses
Prevention
Verbal Rating Scale
infection control
---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care
---
https://www.srlf.org/article/20-ans-davancees-nouveau-souffle-bpco
2024
France
critical appraisal or critical reading
Heart Murmur
Newar Language
chronic obstructive lung disease, nos
Karnofsky Performance Status 20
pulmonary disease, chronic obstructive
Twenty
Chronic Obstructive Pulmonary Disease
blast
New Lesion Identification
Copeptin Measurement
Lansky Performance Status 20
COPP Regimen
Stooping
COPD Assessment Test Questionnaire
Autonomic Nervous System
Blowing Heart Murmur
Andorra
How Worried
Cyclophosphamide/Vincristine/Prednisone/Bleomycin Regimen
---
https://ansm.sante.fr/informations-de-securite/pseudoephedrine-risques-de-syndrome-dencephalopathie-posterieure-reversible-pres-et-de-syndrome-de-vasoconstriction-cerebrale-reversible-rcvs
2024
false
false
false
France
French
pharmacovigilance note
pseudoephedrine
Posterior reversible encephalopathy syndrome (disorder)
posterior leukoencephalopathy syndrome
Reversible cerebral vasoconstriction syndrome (disorder)
cerebrovascular disorders
pseudoephedrine
administration, oral
nasal decongestants
pseudoephedrine, combinations
---
https://www.has-sante.fr/jcms/p_3492882/fr/alvesco-ciclesonide-asthme
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
glucocorticoids
administration, inhalation
ciclesonide
evaluation of the transparency committee
asthma
ciclesonide
---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma
---
https://www.has-sante.fr/jcms/p_3468175/fr/imfinzi-durvalumab-cancer-des-voies-biliaires
2024
false
false
false
France
Cisplatin/Durvalumab/Gemcitabine Regimen
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
cisplatin
Gemcitabine
Unresectable Biliary Tract Carcinoma
Metastatic Biliary Tract Carcinoma
neoplasm metastasis
Antineoplastic Agents, Immunological
durvalumab
adult
guidelines for drug use
evaluation of the transparency committee
biliary tract cancer
biliary tract neoplasms
durvalumab
---
https://www.has-sante.fr/jcms/p_3498750/fr/keytruda-pembrolizumab-carcinome-a-cellules-renales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
antineoplastic combined chemotherapy protocols
clear cell renal cell carcinoma
Lenvatinib/Pembrolizumab Regimen
Advanced Clear Cell Renal Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
pembrolizumab
evaluation of the transparency committee
pembrolizumab
carcinoma, renal cell
---
https://www.has-sante.fr/jcms/p_3499784/fr/prolastin-alpha-1-antitrypsine-humaine-deficit-en-alpha-1-antitrypsine
2024
false
false
false
France
insurance, health, reimbursement
alfa1 antitrypsin
alpha 1-Antitrypsin
alpha 1-antitrypsin deficiency
Product containing only human alpha1 proteinase inhibitor in parenteral dose form
(medicinal product form)
evaluation of the transparency committee
---
https://www.inrs.fr/media.html?refINRS=TD%20309
2024
France
journal article
What Month is it
Post-Acute Sequelae of COVID-19
Thought Score 6
occupational health
occupation, nos
effects of exposure to external cause, nos
Scientist
kidney function tests
Smoking at Diagnosis
Illness Intrusiveness Rating 6
Occupational Health
respiratory function tests
Science
Fear Score 6
Post-Acute COVID-19 Syndrome
Severity of Symptom Score 6
Balance Sheet
Work-up
October
Six
health fairs
measurement of respiratory function, nos
Clinical Status Ordinal Scale Outcome 6
---
https://www.cbip.be/fr/articles/4277?folia=4275
2024
false
false
false
Belgium
French
journal article
drug information
pulmonary disease, chronic obstructive
administration, inhalation
Chronic obstructive pulmonary disease exacerbation
comparative effectiveness research
glucocorticoids
adrenergic beta-2 receptor agonists
Long-Acting beta2-adrenergic receptor Agonist
long-acting anticholinergic
cholinergic antagonists
bronchodilator agents
---
https://www.has-sante.fr/jcms/p_3500927/fr/adempas-riociguat-hypertension-arterielle-pulmonaire-htap
2024
false
false
false
France
administration, oral
insurance, health, reimbursement
treatment outcome
drug therapy, combination
Endothelin Receptor Antagonists
child
adolescent
Pulmonary arterial hypertension WHO functional class II
Pulmonary arterial hypertension WHO functional class III
evaluation of the transparency committee
riociguat
Pulmonary Arterial Hypertension
---
https://www.ema.europa.eu/en/medicines/human/EPAR/lyfnua
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Gefapixant
Gefapixant
gefapixant
drug approval
europe
purinergic P2X3 receptor antagonists
purinergic P2X3 receptor antagonists
purinergic P2X receptor antagonists
purinergic P2X receptor antagonists
Chronic Cough
adult
pregnancy
breast feeding
drug interactions
administration, oral
risk management
product surveillance, postmarketing
Refractory chronic cough (disorder)
Unexplained chronic cough (disorder)
aged
drug evaluation, preclinical
---
https://minerva-ebp.be/FR/Analysis/855
2024
Belgium
critical appraisal or critical reading
pulmonary embolism
guideline
anticoagulants
anticoagulotherapy
leadership
Anticoagulation Therapy
Update
anticoagulant, nos
Pulmonary Embolism
Direct Oral Anticoagulant
pulmonary embolism
Long-Term
pulmonary embolism
oral anticoagulants
Software Maintenance
---
https://minerva-ebp.be/FR/Article/2368
2024
Belgium
critical appraisal or critical reading
Kinked
dyspnea, nos
Effort
Patient
infectious disease, nos
dyspnea
Dyspnea, CTCAE
Person Initials
has patient
No Effort
physical exertion
Assistance
patients
ventilation, mechanical
masseur
Infection
European Union
Ehrlich Unit
What Month is it
rehabilitation
Adverse Event Associated with Infection
Post-Acute COVID-19 Syndrome
exertion, nos
mechanical ventilation, nos
Mechanical Ventilation
physical therapy specialty
respiration, artificial
counseling
Post-Acute Sequelae of COVID-19
physical therapists
Dyspnea
---
https://www.srlf.org/article/phenotypage-du-sdra-ca-marche-pediatrie
2024
France
critical appraisal or critical reading
SLC5A8 wt Allele
Markup
Calcium
Acute Respiratory Distress Syndrome
Calcium Cation
Ca2+
id
Malignant Neoplasm
Cyclophosphamide/Doxorubicin
Walking
CA Mouse
Calcium Measurement
Cornu Ammonis
gait, nos
California
Marketing
adult respiratory distress syndrome, nos
Over the Counter Product
European Union Competent Authority
Canada
Respiratory Distress Syndrome
---
https://www.has-sante.fr/jcms/p_3505636/fr/rybrevant-amivantamab-cancer-bronchique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
carboplatin
amivantamab
Antineoplastic Agents, Immunological
bispecific monoclonal antibodies
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
carcinoma, non-small-cell lung
carcinoma, non-small-cell lung
Activating EGFR Exon 20 Mutation
EGFR Exon 20 Insertion Mutation
Pemetrexed
adult
package leaflet
summary of product characteristics
guidelines for drug use
infusions, intravenous
evaluation of the transparency committee
bronchial neoplasms
amivantamab
---
https://www.has-sante.fr/jcms/p_3505761/fr/retsevmo-selpercatinib-cancer-bronchique-non-a-petites-cellules
2024
false
false
false
France
bronchial neoplasms
adult
treatment outcome
insurance, health, reimbursement
antineoplastic agents
administration, oral
selpercatinib
package leaflet
summary of product characteristics
guidelines for drug use
advanced RET fusion-positive non-small cell lung cancer
RET Fusion Positive
carcinoma, non-small-cell lung
Advanced Lung Non-Small Cell Carcinoma
evaluation of the transparency committee
selpercatinib
carcinoma, non-small-cell lung
---
https://ansm.sante.fr/actualites/avis-de-lansm-du-11-03-2024-sur-le-medicament-keytruda-dans-le-cadre-dune-demande-daap
2024
false
false
false
France
French
treatment outcome
pembrolizumab
Antineoplastic Agents, Immunological
drug information
Resectable Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
neoplasm recurrence, local
risk
pembrolizumab
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/portrait-de-la-maladie-pulmonaire-obstructive-chronique-au-quebec-de-2016-a-2022-resultats-dindicateurs-sur-le-parcours-de-soins.html
2024
Canada
technical report
Status
critical pathways
State
Care
portraits as topic
quebec
nursing
chronic obstructive lung disease, nos
pulmonary disease, chronic obstructive
How True Feel Carefree Right Now
Chronic Obstructive Pulmonary Disease
Portrait
US State
Healthcare Activity
resulting in
lung diseases
State Ownership
Healthcare
chronic disease
indication of
outcome measures
suggestive of
Outcome Assessment, Health Care
---
https://www.cochrane.org/fr/CD009609/ARI_oxygenotherapie-par-canules-nasales-haut-debit-chez-les-nourrissons-atteints-de-bronchiolite
2024
United Kingdom
review of literature
french abstract
Cannula Device
cannula, nos
oxygen inhalation therapy
High Level
Nasal Cannula
bronchiolitis, nos
cannulation, nos
disease
Value Above Reference Range
Nasal Route of Administration
Oxygen Therapy
Warburg Therapy
infant
IPSS Risk Category High
IPSS-R Risk Category High
Topical Route of Administration
bronchiolitis
Output
Topical Dosage Form
High Mitosis-Karyorrhexis Index
nose, nos
Backflow
oxygen therapy, nos
High-Frequency Microsatellite Instability
Bronchiolitis
Turkmen Language
Cannula
Nasal Dosage Form
---
https://www.has-sante.fr/jcms/p_3471694/fr/orkambi-lumacaftor/ivacaftor-mucoviscidose
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
lumacaftor, ivacaftor drug combination
drug combinations
ivacaftor
lumacaftor
ivacaftor and lumacaftor
infant
administration, oral
evaluation of the transparency committee
cystic fibrosis
---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child
---
https://www.srlf.org/media/phenotypage-du-sdra-caracteristiques-perspectives
2024
France
sound
Characteristic
Respiratory Distress Syndrome
Outlook Distress
adult respiratory distress syndrome, nos
Outlook
Acute Respiratory Distress Syndrome
---
https://www.santepubliquefrance.fr/presse/2024/bronchiolite-deux-etudes-francaises-demontrent-l-efficacite-du-beyfortus-R-dans-la-prevention-des-cas-graves-et-la-reduction-des-hospitalisations
2024
France
scientific and technical information
BCAR1 wt Allele
hospitalization
Bronchiolitis
No Cases Transmission Pattern
Reduction
Packaging Case
infant
CTNND1 wt Allele
Reduced
Catenin Delta-1
Coronavirus Anxiety Scale
efficiency
Twice
Case
Efficacy Study
hospital admission, nos
bronchiolitis, nos
Case Dosing Unit
bronchiolitis
Breast Cancer Anti-Estrogen Resistance Protein 1
Prevention
True Case Status
Hospitalization
Prevention Study
Preventive Intervention
snacks
---
https://ansm.sante.fr/actualites/decision-du-06-05-2024-renouvellement-du-cpc-du-medicament-imfinzi-durvalumab-50-mg-ml-solution-a-diluer-pour-perfusion
2024
false
false
false
France
French
drug information
durvalumab
---
https://www.ssmg.be/wp-content/uploads/RMG/409/RMG409_06-10.pdf
2024
Belgium
journal article
Integrator Device
chronic obstructive lung disease, nos
Respiratory System
COPP Regimen
COPD Assessment Test Questionnaire
has patient
Patient Load
Copeptin Measurement
case management
Respiratory System Finding
pulmonary disease, chronic obstructive
Integrated
rehabilitation
Cyclophosphamide/Vincristine/Prednisone/Bleomycin Regimen
Chronic Obstructive Pulmonary Disease
---
https://www.has-sante.fr/jcms/p_3506840/fr/imfinzi-durvalumab-cancer-bronchique-non-a-petites-cellules
2024
false
false
false
France
evaluation of the transparency committee
Imfinzi
Durvalumab
durvalumab
durvalumab
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/dosage-plasmatique-du-linezolide.html
2024
Canada
health technology assessment
Bioassay
Linezolid
Linezolid
Assessment
Cumulative Dose
---
https://www.has-sante.fr/jcms/p_3517566/fr/kaftrio-ivacaftor/tezacaftor/elexacaftor-en-association-avec-kalydeco-ivacaftor-mucoviscidose-de-2-ans-a-moins-de-6-ans
2024
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
drug combinations
drug therapy, combination
elexacaftor, ivacaftor, tezacaftor drug combination
elexacaftor
tezacaftor
ivacaftor
ivacaftor, tezacaftor and elexacaftor
administration, oral
evaluation of the transparency committee
cystic fibrosis
ivacaftor
---
https://www.has-sante.fr/jcms/p_3517160/fr/tecentriq-atezolizumab-oncologie
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only atezolizumab in parenteral dose form (medicinal product form)
atezolizumab
antineoplastic combined chemotherapy protocols
Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel Regimen
neoplasm metastasis
carcinoma, non-small-cell lung
small cell lung carcinoma
Extensive Stage Lung Small Cell Carcinoma
antineoplastic agents
Unresectable Hepatocellular Carcinoma
Advanced Hepatocellular Carcinoma
carcinoma, hepatocellular
evaluation of the transparency committee
atezolizumab
---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide
---
https://www.cochrane.org/fr/CD015306/ARI_supplementation-orale-en-vitamine-pour-prevenir-les-infections-aigues-des-voies-respiratoires
2024
United Kingdom
review of literature
french abstract
Advanced Glycation End Product
Infections
Autonomic Nervous System
3-dehydroretinol
Child
Oral Route of Administration
D Vitamin
Offspring
Elderly
vitamins
Respiratory System
respiratory tract
acute infectious disease
child, nos
respiratory tract infections
vitamin, nos
Infection
administration, oral
child
attentiveness
Nutritional Supplementation
Subject Age
age, nos
---
https://www.has-sante.fr/jcms/p_3519011/fr/xolair-omalizumab-asthme-allergique-urticaire-chronique-spontanee
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
asthma
Allergic asthma (disorder)
injections, subcutaneous
anti-asthmatic agents
anti-allergic agents
evaluation of the transparency committee
Omalizumab
Chronic Spontaneous Urticaria
Chronic Urticaria
---
https://www.has-sante.fr/jcms/p_3519904/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2024
false
false
false
France
antineoplastic combined chemotherapy protocols
endometrial neoplasms
evaluation of the transparency committee
durvalumab
olaparib
---
https://www.cochrane.org/fr/CD012361/NEONATAL_utilisation-de-la-dexmedetomidine-pour-reduire-la-douleur-et-induire-le-sommeil-chez-les-nouveau-nes
2024
United Kingdom
review of literature
french abstract
Newar Language
Neck Pain Score 0
Pain
No Extremity Pain
dexmedetomidine
Sleep
Pain by Anatomic Descriptor, CTCAE
How Much Distress Pain
sleep
Use
NES Gene
newborn, nos
pain, nos
counseling
Usual Severity Pain
Assistance
EPO wt Allele
Ras-Interacting Protein 1
Stain
Staining Method
infant, newborn
New Lesion Identification
Dexmedetomidine
respiration, artificial
pain
ventilation, nos
Had No Pain
Ventilation
Hour Of Sleep
Theophylline
sleep, nos
Pain Distress
Induction
ventilation
---
https://www.cochrane.org/fr/CD009530/CF_utilisation-dechantillons-obtenus-par-bronchoscopie-pour-decider-comment-traiter-les-infections
2024
United Kingdom
review of literature
french abstract
People
bronchoscopy
persons
Bronchoscopy
Infectious Lung Disorder
cystic fibrosis
Cystic Fibrosis
Infections
specimen processing, nos
pulmonary cystic fibrosis
cystic fibrosis of the lung
Specimen Processing
infectious disease, nos
medical waste disposal
bronchoscopy, nos
disease
Use
---
https://www.ema.europa.eu/en/medicines/human/EPAR/emblaveo
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
drug combinations
avibactam
avibactam
aztreonam
aztreonam
anti-bacterial agents
anti-bacterial agents
adult
beta-Lactamase Inhibitors
beta-Lactamase Inhibitors
intraabdominal infections
complicated intra-abdominal infections
Healthcare-Associated Pneumonia
pyelonephritis
Gram-Negative aerobic bacteria
Gram-Negative bacterial infections
infusions, intravenous
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
aztreonam and beta-lactamase inhibitor
---
https://www.ema.europa.eu/en/medicines/human/EPAR/naveruclif
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
paclitaxel
paclitaxel
drugs, generic
---
https://www.has-sante.fr/jcms/p_3517440/fr/moovcare-poumon
2024
France
health technology assessment
telemedicine
Lung
Uracil-DNA Glycosylase
Biochemical Activity
Murine Lung
Activity
BPIFA1 wt Allele
FDA Establishment Activity Terminology
Active
UNG Gene
lung
---
https://conseil-scientifique.public.lu/fr/publications/risques-vasculaires/role-des-premiers-intervenants-dans-la-prise-en-charge-d-un-patient-adulte-en-arret-cardio-respiratoire-non-traumatique-en-dehors-de-l-hopital-version-longue.html
https://conseil-scientifique.public.lu/fr/publications/risques-vasculaires/role-des-premiers-intervenants-dans-la-prise-en-charge-d-un-patient-adulte-en-arret-cardio-respiratoire-non-traumatique-en-dehors-de-l-hopital-arbre-decisionnel.html
2024
Luxembourg
guideline
algorithms
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
RET Rearrangement Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
Caffeine Not Routinely Consumed
ATRX Gene Mutation Negative
Medication Not Taken
ATRX Mutation Analysis Was Not Performed
wounds and injuries
Adjuvant Post-operative Radiation Therapy Was Not Administered
Local Anesthesia Agents were not Administered
Evidence of Disease Absent after Completion of Therapy
Patient was Not Previously Evaluated for Current Chief Complaint
Tumor Reoccurrence Absent After Initial Treatment
Another Form of Birth Control was not Used
No History of Gestational Complication
No History of Kawasaki Disease
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
BRAF Rearrangement Analysis Was Not Performed
Preoperative IV Antiemetics were not Administered
Nitric Oxide Measurement
SDH Complex Mutation Analysis Was Not Performed
IV Anesthesia was not Administered
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Congenital Heart Disease
No History of Non-Cardiac Surgery
Paraneoplastic Syndrome is Not Present
Negation
Cancer History Absent
Norway
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Legal Adult
Patient was not Postmenopausal with no Prior Oophorectomy
First Degree Family History of Primary Brain Tumor Negative
NF1 Mutation Analysis Was Not Performed
case management
Role Entity
ERBB2 Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
First Degree Family History Thyroid Cancer Negative
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
New Disease is not Multifocal
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
PTEN Mutation Analysis Was Not Performed
Intervention Not Given for Kawasaki Disease
Regional Anesthesia was not Administered
MGMT Promoter Methylation Testing Was Not Performed
Neither Case or Control Status
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
MET Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Family History of Stomach Cancer Absent
Physician Diagnosed Diabetes Absent
KRAS Mutation Analysis Was Not Performed
Additional Surgery for New Tumor Event Absent
EGFR Amplification Analysis Was Not Performed
10q23/PTEN Locus Deletion Analysis Was Not Performed
1p/19q Deletion Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
Respiratory Arrest
Lymph Node Dissection Was Not Performed
Unemployed
Social Role
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
adult
Neither
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Routine Cytogenetics Were not Completed
No History of Myopathy
No Known History of Illicit Drug Use
History of Colorectal Cancer Negative
Preoperative IV Antacids were not Administered
EGFR Gene Amplification Negative
First Degree Family History Cancer Negative
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
No Response to Intervention for Kawasaki Disease
Adjuvant Post-operative Chemotherapy Was Not Administered
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Not Lost to Follow-Up
Nitric Oxide
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Minor Criteria for Rheumatic Heart Disease Not Present
Patient Load
Chemotherapy Not Received
Additional Immunohistochemistry Was Not Performed
EGFR Mutation Analysis Was Not Performed
Security Role Object
NON Mouse
History of Medical Treatment Absent
IDH Family Wildtype
Injury
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Preoperative IV Sedation was Not Administered
KIT Mutation Analysis Was Not Performed
No Known History of Alcohol Use
Chief Complaint Not Caused by Trauma
Any Metastatic Diagnosis Absent
has patient
NCI Thesaurus Role
IDH Family Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
Has No Sibling
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Rheumatic Fever
hospitals
PDGFRA Mutation Analysis Was Not Performed
Fluorescence In Situ Hybridization Was Not Performed
ALK Rearrangement Analysis Was Not Performed
Additional Molecular Studies Were Not Performed
adulthood
No History of Neonatal Complication
hospital, nos
ROS1 Rearrangement Analysis Was Not Performed
injury, nos
PTEN Gene Mutation Negative
Preoperative IV Opiates were not Administered
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Documentation Absent
role
TP53 Mutation Analysis Was Not Performed
Therapeutic Ionizing Radiation to Head History Absent
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event
respiratory arrest
NRAS Mutation Analysis Was Not Performed
Tumor Progression Absent After Initial Treatment
Chemical/Occupational Exposure Absent
New Tumor Event After Initial Treatment Absent
BRAF Mutation Analysis Was Not Performed
Radiation Therapy Not Received
Radiation History Negative
Hypertension Absent
---
https://ansm.sante.fr/actualites/a-compter-du-10-07-2024-la-cyproheptadine-periactine-4mg-sera-dispensee-uniquement-sur-ordonnance
2024
false
false
false
France
French
drug information
cyproheptadine
cyproheptadine
prescription drugs
Off-Label use
---
https://www.has-sante.fr/jcms/p_3527277/fr/opdivo-nivolumab-cancer-bronchique-cbnpc
2024
false
false
false
France
evaluation of the transparency committee
Nivolumab
cancer
Malignant Neoplasm
bronchus, nos
neoplasm, malignant
Bronchial
carcinoma, non-small-cell lung
Opdivo
nivolumab
Nivolumab
---
https://www.has-sante.fr/jcms/p_3527216/fr/afinitor-everolimus-tumeurs-neuroendocrines-d-origine-pancreatique
2024
false
false
false
France
pancreatic neoplasms
treatment outcome
insurance, health, reimbursement
disease progression
adult
Metastatic Pancreatic Neuroendocrine Tumor
Unresectable Pancreatic Neuroendocrine Tumor
administration, oral
antineoplastic agents
everolimus
evaluation of the transparency committee
neuroendocrine tumors
Everolimus
---
https://www.cfp.ca/content/70/11-12/e187
2024
Canada
journal article
infant
respiratory syncytial virus infections
immunization, passive
passive immunization
respiratory syncytial virus infection, nos
infection control
---
https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/grippe/documents/bulletin-national/infections-respiratoires-aigues-grippe-bronchiolite-covid-19-.-bulletin-du-11-decembre-2024
2024
France
journal article
acute bronchiolitis, nos
influenza, nos
bronchiolitis
COVID-19
newsletters
Infections
influenza
acute infectious disease
influenza, human
periodicals as topic
---
https://www.chu-lyon.fr/pneumonies-ou-pneumopathies-infectieuses
2024
France
patient education handout
pneumonia
pneumonia
pneumonia, nos
---
https://www.chu-lyon.fr/sarcoidose
2024
France
patient education handout
sarcoidosis, nos
sarcoidosis
---
https://www.chu-lyon.fr/sarcoidose-pulmonaire
2024
France
patient education handout
pulmonary sarcoidosis
sarcoidosis, pulmonary
---
https://www.cochrane.org/fr/CD014541/CENTRALED_une-strategie-danticoagulants-de-longue-duree-pour-prevenir-le-developpement-de-caillots-sanguins
2024
United Kingdom
review of literature
french abstract
duration
hospital, nos
blood clot, nos
anticoagulant, nos
hospitals
lung
anticoagulants
acute disease, nos
resulting in
acute disease
has patient
attentiveness
patients
---
https://www.has-sante.fr/jcms/p_3574980/fr/opdivo-nivolumab-et-yervoy-ipilimumab-cancer-colorectal
2024
false
false
false
France
Ipilimumab/Nivolumab Regimen
evaluation of the transparency committee
Ipilimumab
Nivolumab
Opdivo
ipilimumab
colorectal neoplasms
yervoy
nivolumab
---
https://www.chu-lyon.fr/alterations-des-genes-alk-et-ros1-dans-les-cancers-du-poumon
2024
France
popular works
genes, neoplasm
genes
lung
---
https://www.chu-lyon.fr/asthme
2024
France
popular works
asthma
asthma, nos
asthma
---
https://www.chu-lyon.fr/asthme-allergique
2024
France
popular works
asthma
asthma
extrinsic asthma
---
https://www.chu-lyon.fr/bpco-broncho-pneumopathie-chronique-obstructive
2024
France
popular works
pulmonary disease, chronic obstructive
chronic obstruction
chronic obstructive lung disease, nos
---
https://www.chu-lyon.fr/bronchiolite
2024
France
popular works
bronchiolitis
bronchiolitis, nos
---
https://www.has-sante.fr/jcms/p_3528903/fr/choix-et-durees-d-antibiotherapie-dans-les-exacerbations-aigues-de-bronchopneumopathie-chronique-obstructive-eabpco
2024
France
practice guideline
acute obstruction
choice behavior
Antibiotic
antibiotic therapy
Antibiotic Therapy
lung diseases, obstructive
chronic obstructive lung disease, nos
pulmonary disease, chronic obstructive
Choose
Exacerbation
Chronic Obstructive Pulmonary Disease
---
https://www.has-sante.fr/jcms/p_3530407/fr/cyclophosphamide-accord-cyclophosphamide-cancer-et-maladies-auto-immunes
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only cyclophosphamide in parenteral dose form (medicinal product
form)
precursor cell lymphoblastic Leukemia-Lymphoma
cyclophosphamide
transplantation conditioning
multiple myeloma
hodgkin disease
lymphoma, Non-Hodgkin
ovarian neoplasms
breast neoplasms
neoplasm metastasis
sarcoma, ewing
small cell lung carcinoma
bronchial neoplasms
neuroblastoma
lupus nephritis
Granulomatosis with Polyangiitis
myeloablative agonists
antineoplastic agents, alkylating
immunosuppressive agents
evaluation of the transparency committee
cyclophosphamide
autoimmune diseases
---
https://www.ce-mir.fr/files/medias/documents/14.%20Embolie%20pulmonaire.pdf
2024
France
educational course
pulmonary embolism
Pulmonary Embolism
pulmonary embolism
pulmonary embolism
---
https://www.ce-mir.fr/files/medias/documents/15.%20Insuffisance%20cardiaque%20et%20oed%C3%A8me%20aigu%20pulmonaire%20cardiog%C3%A9nique.pdf
2024
France
educational course
Pulmonary Edema
Inpatient Acute Care Encounter
pulmonary edema
Acute Graft Versus Host Disease
acute pulmonary edema, nos
pulmonary valve insufficiency
Pulmonary Edema, CTCAE
Commute
Heart Failure
cardiac edema
Pulmonary Insufficiency
Pulmonary Valvular Insufficiency
edema, cardiac
acute heart failure
Peracute
---
https://www.ce-mir.fr/files/medias/documents/21.%20Insuffisance%20respiratoire%20aigu%C3%AB%20de%20l%27adulte.pdf
2024
France
educational course
respiratory insufficiency
adult
adulthood
Legal Adult
acute respiratory failure
Acute Respiratory Failure
---
https://www.ce-mir.fr/files/medias/documents/22.%20Insuffisance%20respiratoire%20aigu%C3%AB%20du%20patient%20BPCO.pdf
2024
France
educational course
chronic obstructive lung disease, nos
COPP Regimen
Acute Respiratory Failure
COPD Assessment Test Questionnaire
patients
Copeptin Measurement
Chronic Obstructive Pulmonary Disease
has patient
respiratory insufficiency
Veterinary Patient
Cyclophosphamide/Vincristine/Prednisone/Bleomycin Regimen
pulmonary disease, chronic obstructive
acute respiratory failure
---
https://www.ce-mir.fr/files/medias/documents/23.%20Exacerbation%20s%C3%A9v%C3%A8re%20d%27asthme.pdf
2024
France
educational course
asthma, nos
Severe Adverse Event
Severe Hallucination
Asthma Pathway
asthma
Borg Category-Ratio 10 Perceived Exertion Score 5
Asthma
Intensity and Distress 5
Severe Extremity Pain
severe
Severe Dysplasia
Epidermal cGVHD Score 4
asthma
Exacerbation
---
https://www.ce-mir.fr/files/medias/documents/24.%20Pneumonie%20aigu%C3%AB%20communautaire%20grave.pdf
2024
France
educational course
pneumonia
severe
Acute Pneumonia
community-acquired pneumonia
Serious
pneumonia
pneumonia, nos
---
https://www.ce-mir.fr/files/medias/documents/25.%20H%C3%A9moptysie.pdf
2024
France
educational course
haemoptysis
hemoptysis
Hemoptysis
hemoptysis
---
https://www.ce-mir.fr/files/medias/documents/26.%20%C3%89panchements%20pleuraux%20liquidiens%20et%20pneumothorax.pdf
2024
France
educational course
pleural effusion, nos
pneumothorax, nos
Pleural Effusion
pleural effusion
Pneumothorax, CTCAE
Pneumothorax
pneumothorax
hydrothorax
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/toux
2024
France
educational course
Cough
Standard Moroccan Berber Language
Bothered by Coughing
CES1 wt Allele
cough, nos
cough
Cough, CTCAE
cough
Have Been Coughing
Liver Carboxylesterase 1
How Much Distress Cough
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/bronchiolite-aigue-du-nourrisson
2024
France
educational course
infant
bronchiolitis
Acute Bronchiolitis
acute bronchiolitis, nos
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/asthme
2024
France
educational course
asthma
asthma, nos
asthma
Asthma Pathway
Asthma
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/pneumonies-aigues-communautaires
2024
France
educational course
Acute Pneumonia
pneumonia
pneumonia, nos
community-acquired pneumonia
pneumonia
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/pneumologie-cardiologie/specificites-maladies-genetiques-propos-dune-maladie-genique-mucoviscidose
2024
France
educational course
Cystic Fibrosis
disease, nos
No Evidence of Coronary Artery Disease
sensitivity and specificity
cystic fibrosis
cystic fibrosis
genetics
Disease Steps Clinical Classification
Specificity of Diagnostic Test
disease
specificity
proband
Disease Free
Disease Object
Approximate
genets
Analyte Specificity
hereditary disease, nos
---
https://www.has-sante.fr/jcms/p_3534502/fr/emblaveo-aztreonam/avibactam-infections-graves
2024
false
false
false
France
drug combinations
anti-bacterial agents
treatment outcome
insurance, health, reimbursement
avibactam
Avibactam Sodium
beta-Lactamase Inhibitors
aztreonam
intraabdominal infections
complicated intra-abdominal infections
Complicated intra-abdominal infection
Healthcare-Associated Pneumonia
pneumonia, ventilator-associated
pyelonephritis
urinary tract infections
Gram-Negative bacterial infections
aztreonam and beta-lactamase inhibitor
evaluation of the transparency committee
---
https://www.cbip.be/fr/articles/4381?folia=4379
2024
false
false
false
Belgium
French
belgium
journal article
drug information
insurance, health, reimbursement
Rivaroxaban
rivaroxaban
---
https://publications.msss.gouv.qc.ca/msss/document-003773/
2024
Canada
scientific and technical information
Schedule
Chuvash Language
respiratory syncytial virus infection, nos
Responsive Disease
Program
immunization
Vienna Rectoscopy Score
Questioning
intention
respiratory syncytial virus infections
Response_Gloss
Pet Responds to Presence
immunization programs
health
Scheduled
Respiratory Syncytial Virus Infection
vaccination, nos
Examination Questions
Verbal Rating Scale
Immunization
health personnel
Deimmunization
Health Professional
---
https://www.anses.fr/sites/default/files/VSR2021MPEX0005Ra.pdf
2024
France
technical report
threshold limit values
MATCH Arm EAY131-N
Middle Lobe of the Prostate
BCAR1 wt Allele
Growth Medium
Packaging Case
judgment
benzene
albumin/globulin ratio
Case Dosing Unit
Sontuzumab
Neither Agree or Disagree
CDISC SDTM Route of Administration Terminology
Signal to Noise Ratio
No
Respiratory System Finding
Nano
N Category
research report
Breast Cancer Anti-Estrogen Resistance Protein 1
snacks
N
Software Maintenance
Catenin Delta-1
True Case Status
Regulatory Report
benzene
Newton
respiratory system
Benzene
Tumor to Normal
Forty Three
Coronavirus Anxiety Scale
respiratory tract
TAF8 wt Allele
Update
Middle
A Medium Amount of Time
Medium Growth Rate
Moderately Bothered
bays
No Cases Transmission Pattern
Media
Long-Term
Respiratory System
Medium Heart Murmur
Case
Route of Administration
CTNND1 wt Allele
Short Heart Murmur
inlets
---
https://www.has-sante.fr/jcms/p_3420797/fr/keytruda-pembrolizumab-cancer-du-sein
2024
false
false
false
France
evaluation of the transparency committee
breast neoplasms
pembrolizumab
breast cancer
pembrolizumab
Childhood Breast Carcinoma
Pembrolizumab
neoplasm, malignant
Male Breast Carcinoma
Keytruda
pembrolizumab
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-dun-panel-multigene-diagnostique-pronostique-ou-predictif-pour-le-carcinome-pulmonaire-non-a-petites-cellules-par-biopsie-liquide.html
2024
Canada
health technology assessment
Percent of Predicted Value
Evaluation
Liquid Biopsy
Have Not Been Diagnosed
lung biopsy
Panel Device
biopsy, nos
lung, nos
carcinoma, non-small-cell lung
Diagnosis
Physical Examination
Prognostic
Assessment
liquid substance, nos
Lung Non-Small Cell Carcinoma
evaluation studies as topic
Liquid Biopsy
Assessment
---
https://www.has-sante.fr/jcms/p_3537837/fr/fasenra-benralizumab-granulomatose-eosinophilique
2024
France
evaluation of the transparency committee
Eosinophilia
Granulomatosis
Benralizumab
eosinophils
benralizumab
eosinophilia, nos
eosinophilia
Fasenra
eosinophil
Eosinophilia, CTCAE
Eosinophil
Eosinophil Count
granulomatosis, nos
---
https://www.canal-u.tv/chaines/univ-bordeaux/deficit-en-alpha-1-antitrypsine
2024
France
audiovisual aids
alpha 1-antitrypsin deficiency
alpha-1-antitrypsin deficiency
Alpha-1 Antitrypsin Deficiency
---
https://www.has-sante.fr/jcms/p_3538228/fr/buld-r-10
2024
France
health technology assessment
Severity of Symptom Score 10
Ill-Housed Persons
Output
High Mitosis-Karyorrhexis Index
Backflow
IPSS-R Risk Category High
Antarctica
Hub Device
Homeless
concentration
domicile
Lansky Performance Status 10
High Level
Concentrator Device
attention
Topical Dosage Form
Home Oxygen Therapy
Topical Route of Administration
High-Frequency Microsatellite Instability
Value Above Reference Range
Karnofsky Performance Status 10
Ten
oxygen therapy, nos
IPSS Risk Category High
EXT1 wt Allele
oxygen inhalation therapy
---
https://www.has-sante.fr/jcms/p_3538266/fr/arexvy-vaccin-du-virus-respiratoire-syncytial-vrs-recombinant-avec-adjuvant-virus-respiratoire-syncytial-vrs
2024
false
false
false
France
viral vaccines
vaccine potency
insurance, health, reimbursement
F protein, human respiratory syncytial virus
respiratory syncytial virus vaccines
respiratory syncytial virus infections
aged
risk factors
Subject Risk
evaluation of the transparency committee
vaccination
respiratory syncytial virus vaccines
---
https://www.srlf.org/article/tazocilline-cefepime-reanimation-qui-fait-mieux
2024
France
critical appraisal or critical reading
Cefepime
Device Properties Domain
Reasoning
What Month is it
Dong Chinese
Resuscitation
Cefepime
Foundation for the Accreditation of Cellular Therapy
Doctor of Osteopathic Medicine
Better than Others
cefepime
resuscitation
Improved
Dominican Republic
---
https://www.cbip.be/fr/articles/4397?folia=4395
2024
false
false
false
Belgium
French
drug therapy, combination
pulmonary disease, chronic obstructive
asthma
drug information
journal article
treatment outcome
bronchodilator agents
glucocorticoids
muscarinic antagonists
formoterol, glycopyrronium bromide and beclometasone
vilanterol, umeclidinium bromide and fluticasone furoate
Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate Inhalation Powder
Long-Acting beta2-adrenergic receptor Agonist
adrenergic beta-2 receptor agonists
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1389
2024
France
public health guidelines
judgment
viruses
transplants
lung transplantation
tissue and organ harvesting
organ part
COVID-19
lung
virus, nos
influenza, human
influenza
organ harvesting
influenza, nos
transplant, nos
---
https://sante.gouv.fr/actualites/presse/communiques-de-presse/article/bronchiolite-du-nourrisson-les-autorites-de-sante-lancent-la-campagne-nationale
2024
France
scientific and technical information
seasons
infant
health campaigns
rural health
health promotion
bronchiolitis, nos
bronchiolitis
Infant Health
---
https://publications.msss.gouv.qc.ca/msss/document-003781/
2024
Canada
patient education handout
immunization
respiratory syncytial viruses
infant, newborn
vaccination, nos
respiratory syncytial virus infection, nos
respiratory syncytial virus infections
---